The blood pressure reduction is comparable or slightly better
Redaccin Farmacosalud.com Llega a Espaa semaglutida oral (Rybelsus ), el primer anlogo del GLP-1 oral para el manejo integral temprano de la diabetes tipo 2

Immediate medical attention is warranted if you develop concerning symptoms, including: Severe or persistent abdominal pain, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 receptor agonists [1] [3] Severe upper abdominal or right-upper-quadrant pain, fever or jaundice, which may indicate gallbladder disease Persistent nausea, vomiting, or diarrhoea leading to dehydration or inability to keep fluids down Signs of hypoglycaemia (if taking concurrent insulin or sulphonylureas)tremor, sweating, confusion, palpitations Unexplained weight gain, particularly if rapid or associated with oedema New or worsening visual symptoms, especially if you have pre-existing diabetic retinopathy A comprehensive medication review should be arranged if you are taking multiple medications, as drug interactions or weight-promoting agents may require adjustment
Straume, O., Sviland, L
If blur persists beyond 6 weeks or worsens, contact your eye doctor to rule out other causes
Tesamorelin + Ipamorelin Blend Half Life Explained The peptide blends that show the most promise in growth hormone research studies consistently fail in one specific area: dosing protocol design